Bellerophon Therapeutics
BLPH
$0.05130
Share price
-6.90%
Change (1 day)
-99.34%
Change (1 year)
Categories
Bellerophon Therapeutics (BLPH) - Net assets
Net assets on the balance sheet as of September 2023 : $3.72 M
According to Bellerophon Therapeutics
's latest financial reports the company has $3.72 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Bellerophon Therapeutics - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $2.53 M | -88.28% |
| 2021-12-31 | $21.61 M | -43.48% |
| 2020-12-31 | $38.24 M | 965.14% |
| 2019-12-31 | $3.59 M | -6.87% |
| 2018-12-31 | $3.85 M | -248.65% |
| 2017-12-31 | $-2.6 M | -114.42% |
| 2016-12-31 | $17.99 M | -40.69% |
| 2015-12-31 | $30.33 M | 32.26% |
| 2014-12-31 | $22.93 M | -245.75% |
| 2013-12-31 | $-15.74 M | 41.57% |
| 2012-12-31 | $-11.12 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $38.82 B | 1,042,795.51% | 🇺🇸 USA |
 Baxter BAX | $8.46 B | 227,350.98% | 🇺🇸 USA |
 Lantheus Holdings LNTH | $0.81 B | 21,814.91% | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | $14.82 M | 298.23% | 🇺🇸 USA |